U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173842) titled 'NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder' on Sept. 08.
Brief Summary: Brief Summary The goal of this observational study is to establish a comprehensive biobank and phenotypic data repository for patients diagnosed with bipolar disorder in Turkiye. The study will prospectively collect standardized clinical, demographic, lifestyle, and biological data to create a secure genomic and epigenomic research resource.
The main questions it aims to answer are:
Can large-scale, standardized phenotypic and biological data collection improve the understanding of bipolar disorder subtypes and disease course?
Can...